"Glucose Tolerance Test" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg).
| Descriptor ID |
D005951
|
| MeSH Number(s) |
E01.370.225.124.100.355 E01.370.374.355 E05.200.124.100.355
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Glucose Tolerance Test".
Below are MeSH descriptors whose meaning is more specific than "Glucose Tolerance Test".
This graph shows the total number of publications written about "Glucose Tolerance Test" by people in this website by year, and whether "Glucose Tolerance Test" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 0 | 1 |
| 1997 | 0 | 1 | 1 |
| 1999 | 1 | 2 | 3 |
| 2000 | 1 | 1 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 6 | 7 |
| 2003 | 1 | 4 | 5 |
| 2004 | 0 | 6 | 6 |
| 2005 | 0 | 3 | 3 |
| 2006 | 0 | 4 | 4 |
| 2007 | 0 | 3 | 3 |
| 2008 | 2 | 6 | 8 |
| 2009 | 0 | 10 | 10 |
| 2010 | 0 | 5 | 5 |
| 2011 | 1 | 4 | 5 |
| 2012 | 0 | 7 | 7 |
| 2013 | 3 | 3 | 6 |
| 2014 | 0 | 8 | 8 |
| 2015 | 0 | 3 | 3 |
| 2016 | 1 | 6 | 7 |
| 2017 | 0 | 6 | 6 |
| 2018 | 2 | 6 | 8 |
| 2019 | 0 | 5 | 5 |
| 2020 | 2 | 6 | 8 |
| 2021 | 1 | 2 | 3 |
| 2022 | 0 | 3 | 3 |
| 2024 | 2 | 4 | 6 |
| 2025 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glucose Tolerance Test" by people in Profiles.
-
Genetic Associations With C-peptide Levels Before Type 1 Diabetes Diagnosis in At-risk Relatives. J Clin Endocrinol Metab. 2025 Mar 17; 110(4):e1046-e1050.
-
A Glucose Fraction Independent of Insulin Secretion: Implications for Type 1 Diabetes Progression in Autoantibody-Positive Cohorts. Diabetes Technol Ther. 2025 Mar; 27(3):179-186.
-
Generalizing from qualitative data: a case example using critical realist thematic analysis and mechanism mapping to evaluate a community health worker-led screening program in India. Implement Sci. 2024 12 24; 19(1):81.
-
Insulin clearance at randomisation and in response to treatment in youth with type 2 diabetes: a secondary analysis of the TODAY randomised clinical trial. Diabetologia. 2025 Mar; 68(3):676-687.
-
Metabolic, genetic and immunological features of relatives of type 1 diabetes patients with elevated insulin resistance. J Endocrinol Invest. 2025 Mar; 48(3):765-775.
-
Associations of systemic immune-inflammation index and systemic inflammation response index with maternal gestational diabetes mellitus: Evidence from a prospective birth cohort study. Chin Med J (Engl). 2025 Mar 20; 138(6):729-737.
-
Cystic fibrosis-related diabetes screening at a large pediatric center. Lab Med. 2024 Sep 04; 55(5):580-584.
-
Postpartum Glucose Monitoring in Pregnant Women with Gestational Diabetes Mellitus: A Dual Center Experience. Ann Clin Lab Sci. 2024 May; 54(3):331-334.
-
Is glucose pattern of OGTT associated with late-onset gestational diabetes and adverse pregnant outcomes? Ann Med. 2023; 55(2):2302516.
-
Rosiglitazone improves insulin resistance but does not improve exercise capacity in individuals with impaired glucose tolerance: A randomized clinical study. J Investig Med. 2024 03; 72(3):294-304.